Periodontal Status among women with Polycystic Ovary Syndrome based on medical treatment: A Cross-sectional study

Background Medications for polycystic ovary syndrome (PCOS) are primarily prescribed to manage hormonal imbalances and associated symptoms. However, both the condition itself and certain medications used for its management may have indirect effects that influence periodontal health. This study evaluated the periodontal status of women with PCOS by examining the dichotomous status of medical treatment, whether treatment has been initiated or not. Material and methods A self-administered questionnaire was used to collect demographic information, including age, marital status, treatment status, type of medication used for PCOS, reasons for seeking medical care, and duration of medication use. Clinical examination was conducted to assess periodontal status. Results Participants receiving medication demonstrated significantly lower mean scores for bleeding on probing, shallow periodontal pockets, and deep pockets compared to non-users. Binary logistic regression analysis showed that age, marital status, gingival bleeding, and the presence of shallow and deep pockets were negatively associated with PCOS medication use. Conclusion As growing evidence highlights the potential relationship between PCOS medication and periodontal health, future research should focus on long-term studies that assess periodontal outcomes over extended periods following the initiation of PCOS treatment.